Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Job Harenberg

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Seminars in Thrombosis and Hemostasis|July 17, 2007
Determination of antithrombin-dependent factor Xa inhibitors by prothrombin-induced clotting timeJob Harenberg, Christina Giese, Antje Hagedorn, et al.
Seminars in Thrombosis and Hemostasis|September 24, 2002
Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis modelJob Harenberg, Kawei Zokai, Lukas Piazolo, et al.
European Journal of Clinical Pharmacology|February 20, 2008
Anticoagulant effects of idraparinux after termination of therapy for prevention of recurrent venous thromboembolism: observations from the van Gogh trialsJob Harenberg, Ingrid Jörg, Yvonne Vukojevic, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 12, 2011
Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxabanJob Harenberg, Svetlana Marx, Roland Krämer, et al.
Seminars in Thrombosis and Hemostasis|February 24, 2015
Arterial and venous thrombosis following trauma and major orthopedic surgery: molecular mechanisms and strategies for interventionOla E Dahl, Job Harenberg, Fredrik Wexels, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 29, 2005
Argatroban treatment for patients with intolerance to heparin and hirudinBettina Kemkes-Matthes, Jeanine M Walenga, Job Harenberg, et al.
Seminars in Thrombosis and Hemostasis|January 2, 2014
Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapyShabnam Zolfaghari, Job Harenberg, Lutz Froelich, et al.
MMW Fortschritte Der Medizin|July 9, 2015
[Development of a questionnaire to identify patients' preference for a conventional or a direct oral anticoagulant]Shabnam Zolfaghari, Job Harenberg, Martin Wehling, et al.
Journal of Thrombosis and Thrombolysis|August 4, 2011
Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variabilityJob Harenberg, Roland Krämer, Christina Giese, et al.
Journal of Thrombosis and Thrombolysis|November 14, 2013
Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countriesMartin Krejczy, Job Harenberg, Svetlana Marx, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Seminars in Thrombosis and Hemostasis|July 17, 2007
Determination of antithrombin-dependent factor Xa inhibitors by prothrombin-induced clotting timeJob Harenberg, Christina Giese, Antje Hagedorn, et al.
Seminars in Thrombosis and Hemostasis|September 24, 2002
Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis modelJob Harenberg, Kawei Zokai, Lukas Piazolo, et al.
European Journal of Clinical Pharmacology|February 20, 2008
Anticoagulant effects of idraparinux after termination of therapy for prevention of recurrent venous thromboembolism: observations from the van Gogh trialsJob Harenberg, Ingrid Jörg, Yvonne Vukojevic, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 12, 2011
Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxabanJob Harenberg, Svetlana Marx, Roland Krämer, et al.
Seminars in Thrombosis and Hemostasis|February 24, 2015
Arterial and venous thrombosis following trauma and major orthopedic surgery: molecular mechanisms and strategies for interventionOla E Dahl, Job Harenberg, Fredrik Wexels, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 29, 2005
Argatroban treatment for patients with intolerance to heparin and hirudinBettina Kemkes-Matthes, Jeanine M Walenga, Job Harenberg, et al.
Seminars in Thrombosis and Hemostasis|January 2, 2014
Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapyShabnam Zolfaghari, Job Harenberg, Lutz Froelich, et al.
MMW Fortschritte Der Medizin|July 9, 2015
[Development of a questionnaire to identify patients' preference for a conventional or a direct oral anticoagulant]Shabnam Zolfaghari, Job Harenberg, Martin Wehling, et al.
Journal of Thrombosis and Thrombolysis|August 4, 2011
Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variabilityJob Harenberg, Roland Krämer, Christina Giese, et al.
Journal of Thrombosis and Thrombolysis|November 14, 2013
Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countriesMartin Krejczy, Job Harenberg, Svetlana Marx, et al.
Pageof 11